Showing results (841-850 of 926) with videos related to
Sort By:
Pageof 93
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonistsJason M Elliott, Robert W Carling, Mark Chambers, et al.The British Journal of Dermatology|May 7, 2019
Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomasR Ellis, D Tang, B Nasr, et al.British Journal of Cancer|April 19, 2023
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancerTheodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.The Anthropocene Review|August 4, 2025
High-resolution analysis of the varved succession at Crawford lake across the base of the proposed Crawfordian stage and Anthropocene seriesFrancine Mg McCarthy, R Timothy Patterson, Carling Walsh, et al.International Journal of Neonatal Screening|March 27, 2024
Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UKRachel S Carling, Katy Hedgethorne, Anupam Chakrapani, et al.The Journal of Pharmacology and Experimental Therapeutics|September 27, 2005
TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primatesJohn R Atack, Keith A Wafford, Spencer J Tye, et al.Molecular Metabolism|September 5, 2024
Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in miceTatiana Lopes, David Cd Hope, Jose M Ramos-Pittol, et al.Journal of Medicinal Chemistry|March 19, 2004
3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1Robert W Carling, Kevin W Moore, Leslie J Street, et al.Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists IIJason M Elliott, Robert W Carling, Gary G Chicchi, et al.Neuron|January 17, 2007
Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinaseNobuyuki Kuramoto, Megan E Wilkins, Benjamin P Fairfax, et al.Pageof 93